New processes for preparing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5- yl)pyridin-3-yl)methoxy)benzaldehyde, an agent developed for the treatment of sickle cell disease, and intermediates thereof, are provided herein.
为治疗镰状细胞病而开发的2-羟基-6-((2-(1-异丙基-1H-
吡唑-5-基)
吡啶-3-基)甲氧基)
苯甲醛的制备新工艺及其中间体已在此提供。